Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Ligresti

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Journal of Medicinal Chemistry|June 28, 2011
Investigations on the 4-quinolone-3-carboxylic acid motif. 4. Identification of new potent and selective ligands for the cannabinoid type 2 receptor with diverse substitution patterns and antihyperalgesic effects in miceSerena Pasquini, Maria De Rosa, Valentina Pedani, et al.
The Journal of Nutrition|June 25, 2009
Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker ratsBarbara Batetta, Mikko Griinari, Gianfranca Carta, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 10, 2004
Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potentialGiovanni Appendino, Luciano De Petrocellis, Marcello Trevisani, et al.
European Journal of Medicinal Chemistry|December 9, 2014
Synthesis, biological activity and molecular modeling of new biphenylic carboxamides as potent and selective CB2 receptor ligandsSimone Bertini, Teija Parkkari, Juha R Savinainen, et al.
Gastroenterology|September 2, 2003
An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in miceAngelo A Izzo, Francesco Capasso, Anna Costagliola, et al.
European Journal of Medicinal Chemistry|October 15, 2011
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: an effective scaffold for the design of either CB1 or CB2 receptor ligandsFrancesco Piscitelli, Alessia Ligresti, Giuseppe La Regina, et al.
Bioorganic & Medicinal Chemistry|July 29, 2014
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonistAntonella Brizzi, Francesca Aiello, Pietro Marini, et al.
European Journal of Medicinal Chemistry|November 21, 2012
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agentsStefano Rizzo, Andrea Tarozzi, Manuela Bartolini, et al.
Plos One|April 28, 2010
Exploiting nanotechnologies and TRPV1 channels to investigate the putative anandamide membrane transporterAlessia Ligresti, Luciano De Petrocellis, Dolores Hernán Pérez de la Ossa, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|April 29, 2021
Synthesis and molecular targets of N-13-hydroxy-octadienoyl-ethanolamine, a novel endogenous bioactive 15-lipoxygenase-derived metabolite of N-linoleoyl-ethanolamine found in the skin and salivaFrancesco Tinto, Anne-Sophie Archambault, Élizabeth Dumais, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Journal of Medicinal Chemistry|June 28, 2011
Investigations on the 4-quinolone-3-carboxylic acid motif. 4. Identification of new potent and selective ligands for the cannabinoid type 2 receptor with diverse substitution patterns and antihyperalgesic effects in miceSerena Pasquini, Maria De Rosa, Valentina Pedani, et al.
The Journal of Nutrition|June 25, 2009
Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker ratsBarbara Batetta, Mikko Griinari, Gianfranca Carta, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 10, 2004
Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potentialGiovanni Appendino, Luciano De Petrocellis, Marcello Trevisani, et al.
European Journal of Medicinal Chemistry|December 9, 2014
Synthesis, biological activity and molecular modeling of new biphenylic carboxamides as potent and selective CB2 receptor ligandsSimone Bertini, Teija Parkkari, Juha R Savinainen, et al.
Gastroenterology|September 2, 2003
An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in miceAngelo A Izzo, Francesco Capasso, Anna Costagliola, et al.
European Journal of Medicinal Chemistry|October 15, 2011
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: an effective scaffold for the design of either CB1 or CB2 receptor ligandsFrancesco Piscitelli, Alessia Ligresti, Giuseppe La Regina, et al.
Bioorganic & Medicinal Chemistry|July 29, 2014
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonistAntonella Brizzi, Francesca Aiello, Pietro Marini, et al.
European Journal of Medicinal Chemistry|November 21, 2012
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agentsStefano Rizzo, Andrea Tarozzi, Manuela Bartolini, et al.
Plos One|April 28, 2010
Exploiting nanotechnologies and TRPV1 channels to investigate the putative anandamide membrane transporterAlessia Ligresti, Luciano De Petrocellis, Dolores Hernán Pérez de la Ossa, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|April 29, 2021
Synthesis and molecular targets of N-13-hydroxy-octadienoyl-ethanolamine, a novel endogenous bioactive 15-lipoxygenase-derived metabolite of N-linoleoyl-ethanolamine found in the skin and salivaFrancesco Tinto, Anne-Sophie Archambault, Élizabeth Dumais, et al.
Pageof 12